Developments in the treatment of HIV and chronic hepatitis C Virus Infections - A report from CROI 2015

Research output: Contribution to journalArticle

Abstract

The Conference on Retroviruses and Opportunistic Infections (CROI) 2015 took place February 23-26, 2015, in Seattle, Washington, and brought together researchers from around the world to share important developments and findings in the field of HIV Medicine and related infectious diseases. This report focuses on studies of new antiretroviral drugs and anti-hepatitis C virus therapies that were presented at CROI 2015.

Original languageEnglish (US)
Pages (from-to)323-328
Number of pages6
JournalDrugs of the Future
Volume40
Issue number5
DOIs
StatePublished - May 1 2015

Fingerprint

Infectious Disease Medicine
Retroviridae Infections
Opportunistic Infections
Chronic Hepatitis C
Virus Diseases
Hepacivirus
Research Personnel
HIV
Pharmaceutical Preparations
Therapeutics

Keywords

  • Asunaprevir
  • Beclabuvir
  • Cabotegravir
  • Daclatasvir
  • Dasabuvir
  • Ledipasvir
  • Ombitasvir
  • Paritaprevir
  • Sofosbuvir
  • Tenofovir alafenamide fumarate

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

@article{4a3e45199db246f19a443f5762be1de6,
title = "Developments in the treatment of HIV and chronic hepatitis C Virus Infections - A report from CROI 2015",
abstract = "The Conference on Retroviruses and Opportunistic Infections (CROI) 2015 took place February 23-26, 2015, in Seattle, Washington, and brought together researchers from around the world to share important developments and findings in the field of HIV Medicine and related infectious diseases. This report focuses on studies of new antiretroviral drugs and anti-hepatitis C virus therapies that were presented at CROI 2015.",
keywords = "Asunaprevir, Beclabuvir, Cabotegravir, Daclatasvir, Dasabuvir, Ledipasvir, Ombitasvir, Paritaprevir, Sofosbuvir, Tenofovir alafenamide fumarate",
author = "Stacey Rizza and Zelalem Temesgen",
year = "2015",
month = "5",
day = "1",
doi = "10.1358/dof.2015.040.05.2321111",
language = "English (US)",
volume = "40",
pages = "323--328",
journal = "Drugs of the Future",
issn = "0377-8282",
publisher = "Prous Science",
number = "5",

}

TY - JOUR

T1 - Developments in the treatment of HIV and chronic hepatitis C Virus Infections - A report from CROI 2015

AU - Rizza, Stacey

AU - Temesgen, Zelalem

PY - 2015/5/1

Y1 - 2015/5/1

N2 - The Conference on Retroviruses and Opportunistic Infections (CROI) 2015 took place February 23-26, 2015, in Seattle, Washington, and brought together researchers from around the world to share important developments and findings in the field of HIV Medicine and related infectious diseases. This report focuses on studies of new antiretroviral drugs and anti-hepatitis C virus therapies that were presented at CROI 2015.

AB - The Conference on Retroviruses and Opportunistic Infections (CROI) 2015 took place February 23-26, 2015, in Seattle, Washington, and brought together researchers from around the world to share important developments and findings in the field of HIV Medicine and related infectious diseases. This report focuses on studies of new antiretroviral drugs and anti-hepatitis C virus therapies that were presented at CROI 2015.

KW - Asunaprevir

KW - Beclabuvir

KW - Cabotegravir

KW - Daclatasvir

KW - Dasabuvir

KW - Ledipasvir

KW - Ombitasvir

KW - Paritaprevir

KW - Sofosbuvir

KW - Tenofovir alafenamide fumarate

UR - http://www.scopus.com/inward/record.url?scp=84944897126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944897126&partnerID=8YFLogxK

U2 - 10.1358/dof.2015.040.05.2321111

DO - 10.1358/dof.2015.040.05.2321111

M3 - Article

VL - 40

SP - 323

EP - 328

JO - Drugs of the Future

JF - Drugs of the Future

SN - 0377-8282

IS - 5

ER -